Journal article
Percutaneous Ethanol Injection vs Reoperation for Locally Recurrent Papillary Thyroid Cancer A Systematic Review and Pooled Analysis
JAMA otolaryngology-- head & neck surgery, Vol.141(6), pp.512-518
06/01/2015
DOI: 10.1001/jamaoto.2015.0596
PMID: 25928119
Abstract
IMPORTANCE Reoperation for recurrent papillary thyroid cancer (PTC) can be associated with a high rate of complications and failure to provide lasting remission. Percutaneous ethanol injection (PEI) may be an effective nonsurgical management option for locally recurrent PTC.
OBJECTIVE This systematic analysis of the current literature compares the efficacy and complications related to PEI vs reoperative surgical intervention for treatment of locally recurrent PTC.
DATA SOURCES Original studies were identified using the keywords "thyroid/ethanol" and "recurrent thyroid cancer/repeat surgery."
STUDY SELECTION Studies evaluating reoperation or PEI for lymph node metastases in patients with primary surgery of total thyroidectomy with appropriate lymph node dissection where indicated were included in the analysis for both reoperation and PEI. Animal studies, single case reports, and studies with fewer than 10 lesions were excluded.
DATA EXTRACTION AND SYNTHESIS Outcomes included interval to detection of recurrence, success and failure rates, recurrence rates, complication rates, and follow-up duration. Between-group outcome differences were calculated using random-effects models, and pooled data cross-tabulation and logistic regression analysis were used.
RESULTS In all, 945 publications were identified, and 27 studies met the inclusion criteria. There were no studies that directly compared the 2 treatment techniques. A total of 1617 patients were included in this analysis; 168 (11.4%) were treated with PEI, and 1449 (88.6%) were treated with reoperation. Reoperation was successful in 94.8% of cases compared with an 87.5% success rate for PEI (odds ratio [OR], 2.58; 95% CI, 1.55-4.31; P < .001). The recurrence rates for PEI and reoperation at the site of the treated lesion or elsewhere in the neck were also similar (OR, 1.07; 95% CI, 0.65-1.77; P = .78). Reoperation was associated with a 3.5% pooled risk of complications, while PEI incurred a pooled risk of 1.2%(OR, 2.9; 95% CI, 0.72-12.3; P = .08). However, most studies did not report routine preoperative and postoperative laryngoscopies, an evaluation needed for accurate neural complication analysis associated with each procedure.
CONCLUSIONS AND RELEVANCE High-quality, well-designed studies are needed to evaluate the feasibility of incorporating PEI into the treatment protocol of PTC. Although presently inferior to reoperation, PEI has the potential to be a widely accepted and effective nonsurgical treatment option for limited recurrent PTC in poor surgical candidates or patients seeking to avoid multiple reoperations.
Details
- Title: Subtitle
- Percutaneous Ethanol Injection vs Reoperation for Locally Recurrent Papillary Thyroid Cancer A Systematic Review and Pooled Analysis
- Creators
- Tatyana E. Fontenot - Tulane UniversityAhmad Deniwar - Tulane UniversityParisha Bhatia - Tulane UniversityZaid Al-Qurayshi - Tulane UniversityGregory W. Randolph - Massachusetts Eye and Ear InfirmaryEmad Kandil - Tulane University
- Resource Type
- Journal article
- Publication Details
- JAMA otolaryngology-- head & neck surgery, Vol.141(6), pp.512-518
- Publisher
- Amer Medical Assoc
- DOI
- 10.1001/jamaoto.2015.0596
- PMID
- 25928119
- ISSN
- 2168-6181
- eISSN
- 2168-619X
- Number of pages
- 7
- Language
- English
- Date published
- 06/01/2015
- Academic Unit
- Otolaryngology
- Record Identifier
- 9984702816302771
Metrics
2 Record Views